- Home
- VKTX vs AVNT Comparison
VKTX vs AVNT Comparison
Compare VKTX & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- AVNT
- Stock Information
- Founded
- VKTX 2012
- AVNT 1927
- Country
- VKTX United States
- AVNT United States
- Employees
- VKTX N/A
- AVNT N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- AVNT Major Chemicals
- Sector
- VKTX Health Care
- AVNT Industrials
- Exchange
- VKTX Nasdaq
- AVNT Nasdaq
- Market Cap
- VKTX 2.8B
- AVNT 3.0B
- IPO Year
- VKTX 2015
- AVNT 1993
- Fundamental
- Price
- VKTX $26.12
- AVNT $35.87
- Analyst Decision
- VKTX Buy
- AVNT Strong Buy
- Analyst Count
- VKTX 12
- AVNT 5
- Target Price
- VKTX $84.00
- AVNT $49.40
- AVG Volume (30 Days)
- VKTX 2.8M
- AVNT 571.1K
- Earning Date
- VKTX 07-23-2025
- AVNT 05-06-2025
- Dividend Yield
- VKTX N/A
- AVNT 3.01%
- EPS Growth
- VKTX N/A
- AVNT N/A
- EPS
- VKTX N/A
- AVNT 1.08
- Revenue
- VKTX N/A
- AVNT $3,238,000,000.00
- Revenue This Year
- VKTX N/A
- AVNT $3.04
- Revenue Next Year
- VKTX N/A
- AVNT $4.10
- P/E Ratio
- VKTX N/A
- AVNT $33.11
- Revenue Growth
- VKTX N/A
- AVNT 3.58
- 52 Week Low
- VKTX $18.92
- AVNT $27.86
- 52 Week High
- VKTX $81.73
- AVNT $54.68
- Technical
- Relative Strength Index (RSI)
- VKTX 45.41
- AVNT 48.49
- Support Level
- VKTX $26.66
- AVNT $35.14
- Resistance Level
- VKTX $28.33
- AVNT $37.35
- Average True Range (ATR)
- VKTX 1.37
- AVNT 0.75
- MACD
- VKTX -0.20
- AVNT -0.18
- Stochastic Oscillator
- VKTX 9.58
- AVNT 17.89
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.